Cencora Inc COR

Morningstar Rating

Strong Performance From Cencora's Specialty Assets Looks Durable and Offsets Industry Headwinds

Business Strategy and Outlook

Cencora is one of three leading domestic wholesalers of branded, generic, and specialty pharmaceutical products. With roughly $300 billion in annual US healthcare distribution sales, Cencora accounts for about a third of the domestic drug distribution market. Its two close competitors are Cardinal Health and McKesson, and the three operate as a pharmaceutical wholesale and distribution oligopoly, supplying over 90% of the US market.

Sponsor Center